GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (LTS:0A4M) » Definitions » Sale Of Investment

DexCom (LTS:0A4M) Sale Of Investment : $3,138 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is DexCom Sale Of Investment?

DexCom's sale of investment for the three months ended in Sep. 2024 was $631 Mil. It means DexCom gained $631 Mil from selling investments. DexCom's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $3,138 Mil.

Compared with last quarter ($667 Mil in Jun. 2024 ), DexCom gained less money from selling investments in Sep. 2024 ($631 Mil).


DexCom Sale Of Investment Historical Data

The historical data trend for DexCom's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Sale Of Investment Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,196.40 2,250.50 2,666.30 2,127.80 2,947.40

DexCom Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 671.40 719.00 1,121.80 666.80 630.60

DexCom Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,138 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DexCom Sale Of Investment Related Terms

Thank you for viewing the detailed overview of DexCom's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom Headlines

No Headlines